Cherie L. Stabler

4.5k total citations
78 papers, 3.4k citations indexed

About

Cherie L. Stabler is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Cherie L. Stabler has authored 78 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Surgery, 29 papers in Endocrinology, Diabetes and Metabolism and 20 papers in Genetics. Recurrent topics in Cherie L. Stabler's work include Pancreatic function and diabetes (55 papers), Diabetes Management and Research (27 papers) and Diabetes and associated disorders (19 papers). Cherie L. Stabler is often cited by papers focused on Pancreatic function and diabetes (55 papers), Diabetes Management and Research (27 papers) and Diabetes and associated disorders (19 papers). Cherie L. Stabler collaborates with scholars based in United States, Switzerland and Italy. Cherie L. Stabler's co-authors include María M. Coronel, Christopher A. Fraker, Kerim M. Gattás‐Asfura, Camillo Ricordi, Jessica D. Weaver, Eileen Pedraza, Elliot L. Chaikof, Xue‐Long Sun, Jia‐Pu Liang and Ying Li and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Cherie L. Stabler

76 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cherie L. Stabler United States 33 1.9k 1.1k 840 773 711 78 3.4k
Teru Okitsu Japan 34 2.4k 1.3× 1.3k 1.2× 833 1.0× 1.2k 1.6× 862 1.2× 129 4.5k
Long‐Hai Wang China 28 760 0.4× 913 0.8× 341 0.4× 546 0.7× 323 0.5× 99 2.5k
Aart A. van Apeldoorn Netherlands 25 903 0.5× 868 0.8× 337 0.4× 448 0.6× 316 0.4× 72 2.1k
Anthony M. Sun Canada 29 3.7k 1.9× 888 0.8× 1.5k 1.7× 1.2k 1.6× 1.4k 1.9× 74 4.8k
Garry P. Duffy Ireland 34 1.1k 0.6× 1.4k 1.3× 169 0.2× 1.0k 1.3× 244 0.3× 79 3.4k
Duo An United States 24 537 0.3× 694 0.6× 205 0.2× 467 0.6× 162 0.2× 31 2.0k
Wanxing Cui United States 19 662 0.3× 252 0.2× 296 0.4× 299 0.4× 305 0.4× 42 1.3k
Jia Xu China 31 520 0.3× 841 0.8× 125 0.1× 1.1k 1.4× 179 0.3× 106 3.0k
Jeong‐Ho Yun South Korea 31 380 0.2× 822 0.8× 291 0.3× 830 1.1× 343 0.5× 103 3.2k
Tram T. Dang United States 12 410 0.2× 1.1k 1.0× 209 0.2× 357 0.5× 79 0.1× 23 2.0k

Countries citing papers authored by Cherie L. Stabler

Since Specialization
Citations

This map shows the geographic impact of Cherie L. Stabler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherie L. Stabler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherie L. Stabler more than expected).

Fields of papers citing papers by Cherie L. Stabler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cherie L. Stabler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherie L. Stabler. The network helps show where Cherie L. Stabler may publish in the future.

Co-authorship network of co-authors of Cherie L. Stabler

This figure shows the co-authorship network connecting the top 25 collaborators of Cherie L. Stabler. A scholar is included among the top collaborators of Cherie L. Stabler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cherie L. Stabler. Cherie L. Stabler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwab, A., L. Brunner, Cherie L. Stabler, et al.. (2025). Clinical course up to 20 years after hantavirus infection. Nephrology Dialysis Transplantation.
2.
Hering, Bernhard J., Michael R. Rickels, Melena D. Bellin, et al.. (2025). Advances in Cell Replacement Therapies for Diabetes. Diabetes. 74(7). 1068–1077. 3 indexed citations
3.
Kotecha, Mrignayani, Long‐Hai Wang, Navin Viswakarma, et al.. (2023). In vitro oxygen imaging of acellular and cell-loaded beta cell replacement devices. Scientific Reports. 13(1). 15641–15641. 13 indexed citations
4.
Liang, Jia‐Pu, et al.. (2023). 3D printed elastomeric biomaterial mitigates compaction during in vitro vasculogenesis. Acta Biomaterialia. 171. 363–377. 3 indexed citations
5.
Mathews, Clayton E., et al.. (2022). The Foundation for Engineering a Pancreatic Islet Niche. Frontiers in Endocrinology. 13. 881525–881525. 13 indexed citations
6.
Liang, Jia‐Pu, et al.. (2021). Controlled Release of Anti-Inflammatory and Proangiogenic Factors from Macroporous Scaffolds. Tissue Engineering Part A. 27(19-20). 1275–1289. 12 indexed citations
7.
Ishahak, Matthew, Deborah Chaimov, Péter Buchwald, et al.. (2021). Organoid microphysiological system preserves pancreatic islet function within 3D matrix. Science Advances. 7(7). 70 indexed citations
8.
Liang, Jia‐Pu, et al.. (2021). Engineering a macroporous oxygen-generating scaffold for enhancing islet cell transplantation within an extrahepatic site. Acta Biomaterialia. 130. 268–280. 48 indexed citations
9.
Kaestner, Klaus H., Martha Campbell‐Thompson, Yuval Dor, et al.. (2021). What is a β cell? – Chapter I in the Human Islet Research Network (HIRN) review series. Molecular Metabolism. 53. 101323–101323. 21 indexed citations
10.
11.
Li, Ying, et al.. (2020). In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition. Biomaterials. 256. 120182–120182. 29 indexed citations
12.
Stabler, Cherie L., Jaime A. Giraldo, Dora M. Berman, et al.. (2019). Transplantation of PEGylated islets enhances therapeutic efficacy in a diabetic nonhuman primate model. American Journal of Transplantation. 20(3). 689–700. 24 indexed citations
13.
Stabler, Cherie L., Ying Li, Joshua M. Stewart, & Benjamin G. Keselowsky. (2019). Engineering immunomodulatory biomaterials for type 1 diabetes. Nature Reviews Materials. 4(6). 429–450. 100 indexed citations
14.
Li, Ying, et al.. (2017). Local delivery of fingolimod from three‐dimensional scaffolds impacts islet graft efficacy and microenvironment in a murine diabetic model. Journal of Tissue Engineering and Regenerative Medicine. 12(2). 393–404. 29 indexed citations
15.
Weaver, Jessica D., Yun Gyu Song, Ethan Yang, et al.. (2015). Controlled Release of Dexamethasone from Organosilicone Constructs for Local Modulation of Inflammation in Islet Transplantation. Tissue Engineering Part A. 21(15-16). 2250–2261. 33 indexed citations
16.
Yang, Ethan, Joshua P. Kronenfeld, Kerim M. Gattás‐Asfura, Allison L. Bayer, & Cherie L. Stabler. (2015). Engineering an “infectious” Treg biomimetic through chemoselective tethering of TGF-β1 to PEG brush surfaces. Biomaterials. 67. 20–31. 22 indexed citations
17.
Martino, Mikaël M., Eileen Pedraza, Antonello Pileggi, et al.. (2013). Proangiogenic Hydrogels Within Macroporous Scaffolds Enhance Islet Engraftment in an Extrahepatic Site. Tissue Engineering Part A. 19(23-24). 2544–2552. 61 indexed citations
18.
Gattás‐Asfura, Kerim M. & Cherie L. Stabler. (2013). Bioorthogonal Layer-by-Layer Encapsulation of Pancreatic Islets via Hyperbranched Polymers. ACS Applied Materials & Interfaces. 5(20). 9964–9974. 59 indexed citations
19.
Song, Yoon‐Jae, Emilio Margolles‐Clark, Christopher A. Fraker, et al.. (2012). Feasibility of localized immunosuppression: 3. Preliminary evaluation of organosilicone constructs designed for sustained drug release in a cell transplant environment using dexamethasone.. PubMed. 67(5). 394–9. 9 indexed citations
20.
Stabler, Cherie L., R. C. Long, Ioannis Constantinidis, & Athanassios Sambanis. (2005). In Vivo Noninvasive Monitoring of a Tissue Engineered Construct Using 1H NMR Spectroscopy. Cell Transplantation. 14(2-3). 139–149. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teru Okitsu Breakdown of academic impact, for papers by Long‐Hai Wang Breakdown of academic impact, for papers by Aart A. van Apeldoorn Breakdown of academic impact, for papers by Anthony M. Sun Breakdown of academic impact, for papers by Garry P. Duffy Breakdown of academic impact, for papers by Duo An Breakdown of academic impact, for papers by Wanxing Cui Breakdown of academic impact, for papers by Jia Xu Breakdown of academic impact, for papers by Jeong‐Ho Yun Breakdown of academic impact, for papers by Tram T. Dang
Rankless by CCL
2026